Expertise in
13
conditions

Angelo Schenone

Genoa, IT 
Expertise in
13
conditions
Genoa, IT 

Overview

Angelo Schenone practices practicing medicine in Genoa, Italy.

Mr. Schenone is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Polyradiculoneuritis, and Infantile Axonal Neuropathy.

He is actively involved in clinical research, co-authoring 193 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Genoa, 16131, Italy
Other Locations
Monza, Italy
Savona, Italy
Milan, Italy
Pavia, Italy
San Martino Di Venezze, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Biological
Study Drug: HYQVIA
Study Phase: Phase 3
View 1 Less Clinical Trial

192 Total Publications

A Consensus Clustering Approach to Amyotrophic Lateral Sclerosis Phenotyping.
A Consensus Clustering Approach to Amyotrophic Lateral Sclerosis Phenotyping.
Journal: Studies in health technology and informatics
Published: May 23, 2026

Frequently Asked Questions about Angelo Schenone

Is Angelo Schenone a top-rated expert for Charcot-Marie-Tooth Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Angelo Schenone is classified as an Elite expert for Charcot-Marie-Tooth Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Angelo Schenone participate in research or clinical trials?

Yes. Angelo Schenone has published 192 articles and abstracts on conditions like Charcot-Marie-Tooth Disease. You can view a list of Angelo Schenone's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schenone's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 52 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile